Related Videos from Youtube

• 
  Stephen Gardner "CSPI Lawsuit...
  A nutrition watchdog group will sue McDonald's if the fast-food chain continues to use toys to promote Happy Meals. According to the nonprofit Center for Science in the Public Interest, using toys to lure small children into McDonald's is unfair and deceptive marketing and is illegal under various state consumer protection laws. CSPI today served McDonald's a notice of its intent to sue, fulfilling a legal requirement of several states in which CSPI might bring the lawsuit. Scott Drake interviews CSPI Litigation Director Stephen Gardner. lbnnews.com
• 
  News Update: McDonald's Corp. CEO A...
  McDonald's Corp. (NYSE:MCD) chief executive Jim Skinner said that he will defend the fast food chain's use of toys to promote Happy Meals to children, amidst a consumer advocacy group's threat to sue McDonald's over the issue. Skinner penned a letter July 6th to the Washington-based Center for Science in the Public Interest's (CSPI) executive director criticizing the consumer group's "inflammatory rhetoric" that putting toys in McDonald's Happy Meals is illegal, deceptive and hooks children. "CSPI is wrong in its assertions and frivolous in its legal threats," wrote Skinner. "CSPI's twisted characterization of McDonald's as 'the stranger in the playground handing out candy to children' is an insult to every one of our franchisees and employees around the world." McDonald's has been criticized in the past for targeting children through marketing, and CSPI officials said in June that the group would sue the fast food giant within 30 days unless it stops promoting Happy Meal sales through toy-related marketing. Officials from the advocacy group cite that toy-related promotions violate consumer protection laws in Texas, Massachusetts, New Jersey, California and the District of Columbia, the Wall Street Journal reports. Shares of McDonald's were trading up 1.4% earlier Wednesday at $67.01, and continue to trade up 1.16% at $66.88.
• 
  Jeff Stier discusses CSPI lawsuit a...
  Jeff Stier of the American Council on Science and Health on CNBC
• 
  CSPI trip...

• 
  FDA Flight No. 106 Captain's announ...
  FujiDreamAirlines(FDA) Flight No. 106 Captain's announcement from Komatsu(KMQ) to Shizuoka(FSZ) Aircraft EMBRAER175(JA03FJ)
• 
  4409 -- FDA employee admits Asparta...
  www.Formula4409.com Help this channel by posting this link on social networks!! http FDA food and drug administration Recalls Market Withdrawals alerts and warnings of foods drugs medical devices cosmetics www.fda.gov Food and Drug Administration 10903 New Hampshire Ave Silver Spring, MD 20993-0002
• 
  Mainstreaming Psychedelics: From FD...
  Google Tech Talk November 17, 2009 ABSTRACT Presented by Rick Doblin, Ph.D., Executive Director MAPS. We're now in the midst of a worldwide renaissance in psychedelic research, after decades of political suppression. Scientists from around the world will present their new findings at the largest psychedelic conference to take place in the US in 17 years, on April 15-18, 2010, in San Jose, CA (www.maps.org ). Even media reports, which usually mention in passing the widespread use of psychedelics by the counterculture in the 1960s, are more hopeful than alarming. In this talk, we'll review the factors which led to the backlash and the lessons to be learned, discuss how the FDA opened the door to research around the world, how the ghost of Timothy Leary was buried at Harvard, and how Burning Man struggles to respond to people who have difficult psychedelic experiences. We'll conclude by explaining how non-profit drug development, initially of MDMA-assisted psychotherapy for postraumatic stress disorder (PTSD), can transform psychedelics into FDA-approved prescription medicines and can lay the groundwork for the successful, long-term integration of psychedelics into the mainstream of medicine, religion, art, creativity, and celebration. Rick founded MAPS in 1986. His dissertation [www.maps.org (Public Policy, Harvards Kennedy School of Government) was on "The Regulation of the Medical Use of Psychedelics and Marijuana," and his masters thesis [www.maps.org (Harvard) focused <b>...</b>
• 
  FDA...